296 related articles for article (PubMed ID: 11873307)
21. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
22. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
23. [New cytogenetic classification of precancerous lesions and carcinomas of the endometrium: possibilities and limits of immunohistochemical differentiation].
Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():357-62. PubMed ID: 1724841
[TBL] [Abstract][Full Text] [Related]
24. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
Nucci MR; Prasad CJ; Crum CP; Mutter GL
Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
[TBL] [Abstract][Full Text] [Related]
25. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
[TBL] [Abstract][Full Text] [Related]
26. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
Horn LC; Bilek K; Schnurrbusch U
Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
[TBL] [Abstract][Full Text] [Related]
27. [Endometrial carcinoma and precursor lesions].
Djordjević B; Stanojević Z
Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
[TBL] [Abstract][Full Text] [Related]
28. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability.
Jovanovic AS; Boynton KA; Mutter GL
Cancer Res; 1996 Apr; 56(8):1917-21. PubMed ID: 8620514
[TBL] [Abstract][Full Text] [Related]
29. Tamoxifen-associated polyps (basalomas) arising in multiple endometriotic foci: A case report and review of the literature.
Schlesinger C; Silverberg SG
Gynecol Oncol; 1999 May; 73(2):305-11. PubMed ID: 10329051
[TBL] [Abstract][Full Text] [Related]
30. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
[TBL] [Abstract][Full Text] [Related]
31. Precursors of endometrial clear cell carcinoma.
Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
33. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy.
Cohen I
Maturitas; 2008 Jan; 59(1):99-100. PubMed ID: 18162338
[No Abstract] [Full Text] [Related]
34. Diagnosis and follow-up of atypical hyperplasia of corpus endometrium--a critical methodological investigation.
Geppert M; Smyczek-Gargya B; Menton M
Zentralbl Gynakol; 1993; 115(11):492-4. PubMed ID: 8296494
[TBL] [Abstract][Full Text] [Related]
35. Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.
Dal Cin P; Timmerman D; Van den Berghe I; Wanschura S; Kazmierczak B; Vergote I; Deprest J; Neven P; Moerman P; Bullerdiek J; Van den Berghe H
Cancer Res; 1998 Jun; 58(11):2278-81. PubMed ID: 9622058
[TBL] [Abstract][Full Text] [Related]
36. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis of precancerous lesions of the endometrium].
Iwasaki H; Shirasawa H; Inaba N; Takeda B; Takamizawa H; Kasai T; Kubota K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1605-11. PubMed ID: 2730055
[TBL] [Abstract][Full Text] [Related]
38. The endometrium in breast cancer patients on tamoxifen.
Dallenbach-Hellweg G; Schmidt D; Hellberg P; Bourne T; Kreuzwieser E; Dören M; Rydh W; Rudenstam G; Granberg S
Arch Gynecol Obstet; 2000 Apr; 263(4):170-7. PubMed ID: 10834325
[TBL] [Abstract][Full Text] [Related]
39. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR
Hum Reprod; 2006 Feb; 21(2):545-53. PubMed ID: 16210385
[TBL] [Abstract][Full Text] [Related]
40. [Changes in the endometrium after tamoxifen therapy].
Schmidt D
Pathologe; 2006 Feb; 27(1):27-32. PubMed ID: 16362260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
